Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers

Documenti analoghi

• Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data
  di: Gupta, Pankaj, et al.
  Pubblicazione: (2012)
• Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
  di: Miyoshi, So, et al.
  Pubblicazione: (2019)
• Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers
  di: Lee, Y, et al.
  Pubblicazione: (1999)
• Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure and Support Dosing Recommendations for Potential Drug‐Drug Interactions or in Special Populations: An Example Using Tofacitinib
  di: Tse, Susanna, et al.
  Pubblicazione: (2020)
• Effect of the Hepatitis C Virus Protease Inhibitor Faldaprevir on the Pharmacokinetics of an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel in Healthy Female Volunteers
  di: Sabo, John P., et al.
  Pubblicazione: (2014)